Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study
ConclusionBoth models have good reliability and validity and have significant clinical value. They can help doctors better assess the risk of developing CRA in lung cancer patients. CRP is a risk factor for CRA in lung cancer patients with normal serum iron but not in patients with decreased serum iron. Therefore, whether CRP and the inflammatory state represented by CRP will further aggravate the decrease in serum iron levels, thus contributing to anemia, warrants further study.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Quan ‐yao Li,
Wen‐xiao Yang,
Hui Liu,
Jia‐lin Yao,
Qin Wang,
Dan Lin,
Jun Shi Tags: RESEARCH ARTICLE Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Cholesterol | Iron | Lung Cancer | Study | Training | Universities & Medical Training